Cargando…
The neuroimaging of neurodegenerative and vascular disease in the secondary prevention of cognitive decline
Structural brain changes indicative of dementia occur up to 20 years before the onset of clinical symptoms. Efforts to modify the disease process after the onset of cognitive symptoms have been unsuccessful in recent years. Thus, future trials must begin during the preclinical phases of the disease...
Autores principales: | Schaeffer, Morgan J., Chan, Leona, Barber, Philip A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323688/ https://www.ncbi.nlm.nih.gov/pubmed/33433462 http://dx.doi.org/10.4103/1673-5374.303011 |
Ejemplares similares
-
Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease
por: Hanganu, Alexandru, et al.
Publicado: (2016) -
Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions
por: Gómez-Gómez, María Elena, et al.
Publicado: (2019) -
Neuroimaging in the early diagnosis of neurodegenerative disease
por: Stoessl, A Jon
Publicado: (2012) -
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
por: Wang, Xiaoqi, et al.
Publicado: (2020) -
Biological aging processes underlying cognitive decline and neurodegenerative disease
por: Gonzales, Mitzi M., et al.
Publicado: (2022)